Effect of Salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells

Journal of Ethnopharmacology

Volumn 132, Issue 2, 2010, Pages 384-392

  Lv, Zhigang ^a,b   Song, Yafang ^a,b   Xue, Dongying ^a,b   Zhang, Wenwei ^a,b   Cheng, Yang ^a,b,c   Xu, Lieming ^a,b,c  

^a Shanghai Shuguang Hospital   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c State Administration of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 5; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; RAF PROTEIN; SALVIANOLIC ACID B; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; STELLATE CELL; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BENZOFURANS; CELL LINE; DRUGS, CHINESE HERBAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEPATIC STELLATE CELLS; LIVER CIRRHOSIS; MAP KINASE KINASE 3; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 78049382168     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.05.026     Document Type: Article

References (40)

1. Axmann A., Seidel D., Reimann T., Hempel U., Wenzel K.W. Transforming growth factor-beta1-induced activation of the Raf-MEK-MAPK signaling pathway in rat lung fibroblasts via a PKC-dependent mechanism. Biochemical and Biophysical Research Communications 1998, 249:456-460.
2. Caraci F., Gili E., Calafiore M., Failla M., La Rosa C., Crimi N., Sortino M.A., Nicoletti F., Copani A., Vancheri C. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacological Research 2008, 57:274-282.
3. Chang F., Steelman L.S., Lee J.T., Shelton J.G., Navolanic P.M., Blalock W.L., Franklin R.A., McCubrey J.A. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 2003, 17:1263-1293.
4. Cheng Y., Ping J., Xu L.M. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells. Chinese Medical Journal (England) 2007, 120:794-801.
5. Chong H., Vikis H.G., Guan K.L. Mechanisms of regulating the Raf kinase family. Cell Signalling 2003, 15:463-469.
6. Dai C., Yang J., Liu Y. Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. Journal of Biological Chemistry 2003, 278:12537-12545.
7. Das S.K., Vasudevan D.M. Genesis of hepatic fibrosis and its biochemical markers. Scandinavian Journal of Clinical and Laboratory Investigation 2008, 68:260-269.
8. Ding L., Xu J., Luo X., Chegini N. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells. Journal of Clinical Endocrinology and Metabolism 2004, 89:5549-5557.
9. Han J., Molkentin J.D. Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends in Cardiovascular Medicine 2000, 10:19-22.
10. Hsu Y.C., Lin Y.L., Chiu Y.T., Shiao M.S., Lee C.Y., Huang Y.T. Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats. Journal of Biomedical Science 2005, 12:185-195.
11. Huh M.I., Kim Y.H., Park J.H., Bae S.W., Kim M.H., Chang Y., Kim S.J., Lee S.R., Lee Y.S., Jin E.J., Sonn J.K., Kang S.S., Jung J.C. Distribution of TGF-beta isoforms and signaling intermediates in corneal fibrotic wound repair. Journal of Cellular Biochemistry 2009.
12. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
13. Kumar S., Boehm J., Lee J.C. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nature Reviews Drug Discovery 2003, 2:717-726.
14. Leask A. Signaling in fibrosis: Targeting the TGF beta, endothelin-1 and CCN2 axis in scleroderma. Frontiers in Bioscience (Elite Ed) 2009, 1:115-122.
15. Lechuga C.G., Hernandez-Nazara Z.H., Dominguez Rosales J.A., Morris E.R., Rincon A.R., Rivas-Estilla A.M., Esteban-Gamboa A., Rojkind M. TGF-beta1 modulates matrix metalloproteinase-13 expression in hepatic stellate cells by complex mechanisms involving p38MAPK, PI3-kinase, AKT, and p70S6k. American Journal of Physiology: Gastrointestinal and Liver Physiology 2004, 287:G974-G987.
16. Liu C., Liu P., Hu Y., Zhu D. Effects of salvianolic acid-B on TGF-beta 1 stimulated hepatic stellate cell activation and its intracellular signaling. Zhonghua Yi Xue Za Zhi 2002, 82:1267-1272.
17. Liu P., Hu Y.Y., Liu C., Zhu D.Y., Xue H.M., Xu Z.Q., Xu L.M., Liu C.H., Gu H.T., Zhang Z.Q. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World Journal of Gastroenterology 2002, 8:679-685.
18. Moreira R.K. Hepatic stellate cells and liver fibrosis. Archives of Pathology and Laboratory Medicine 2007, 131:1728-1734.
19. Na H.J., Lee S.J., Kang Y.C., Cho Y.L., Nam W.D., Kim P.K., Ha K.S., Chung H.T., Lee H., Kwon Y.G., Koh J.S., Kim Y.M. Inhibition of farnesyltransferase prevents collagen-induced arthritis by down-regulation of inflammatory gene expression through suppression of p21(ras)-dependent NF-kappaB activation. Journal of Immunology 2004, 173:1276-1283.
20. Nakagawa T., Lan H.Y., Glushakova O., Zhu H.J., Kang D.H., Schreiner G.F., Bottinger E.P., Johnson R.J., Sautin Y.Y. Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-beta1 in rat proximal tubular cells and mouse fibroblasts. Journal of the American Society of Nephrology 2005, 16:899-904.
21. Qiao B., Padilla S.R., Benya P.D. Transforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling. Journal of Biological Chemistry 2005, 280:17562-17571.
22. Raman M., Cobb M.H. MAP kinase modules: many roads home. Current Biology 2003, 13:R886-R888.
23. Rippe R.A., Brenner D.A. From quiescence to activation: Gene regulation in hepatic stellate cells. Gastroenterology 2004, 127:1260-1262.
24. Roskams T. Relationships among stellate cell activation, progenitor cells, and hepatic regeneration. Clinics in Liver Disease 2008, 12:853-860. ix.
25. Saika S., Yamanaka O., Ikeda K., Kim-Mitsuyama S., Flanders K.C., Yoo J., Roberts A.B., Nishikawa-Ishida I., Ohnishi Y., Muragaki Y., Ooshima A. Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells. Laboratory Investigation 2005, 85:838-850.
26. Schnabl B., Bradham C.A., Bennett B.L., Manning A.M., Stefanovic B., Brenner D.A. TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells. Hepatology 2001, 34:953-963.
27. Sebe A., Leivonen S.K., Fintha A., Masszi A., Rosivall L., Kahari V.M., Mucsi I. Transforming growth factor-beta-induced alpha-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38beta mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the Smad signalling during epithelial-myofibroblast transdifferentiation. Nephrology Dialysis Transplantation 2008, 23:1537-1545.
28. Sund M., Maeshima Y., Kalluri R. Bifunctional promoter of type IV collagen COL4A5 and COL4A6 genes regulates the expression of alpha5 and alpha6 chains in a distinct cell-specific fashion. Biochemical Journal 2005, 387:755-761.
29. Suzuki H., Uchida K., Nitta K., Nihei H. Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts. Clinical and Experimental Nephrology 2004, 8:188-195.
30. Svegliati-Baroni G., De Minicis S., Marzioni M. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Liver International 2008, 28:1052-1064.
31. Tsukada S., Westwick J.K., Ikejima K., Sato N., Rippe R.A. SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells. Journal of Biological Chemistry 2005, 280:10055-10064.
32. Varela-Rey M., Montiel-Duarte C., Oses-Prieto J.A., Lopez-Zabalza M.J., Jaffrezou J.P., Rojkind M., Iraburu M.J. p38 MAPK mediates the regulation of alpha1(I) procollagen mRNA levels by TNF-alpha and TGF-beta in a cell line of rat hepatic stellate cells(1). FEBS Letter 2002, 528:133-138.
33. Wakefield L.M., Piek E., Bottinger E.P. TGF-beta signaling in mammary gland development and tumorigenesis. Journal of Mammary Gland Biology and Neoplasia 2001, 6:67-82.
34. Wang X., Tang X., Gong X., Albanis E., Friedman S.L., Mao Z. Regulation of hepatic stellate cell activation and growth by transcription factor myocyte enhancer factor 2. Gastroenterology 2004, 127:1174-1188.
35. Wang X.M., Yu D.M., McCaughan G.W., Gorrell M.D. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology 2005, 42:935-945.
36. Wang X.N., Hu Y.Y., Liu C.H., Liu P., Zhu D.Y. Effects of salvianolic acid B on expressions of TGF-beta1 and its receptors in liver of rats with dimethylnitrosamine-induced hepatic fibrosis. Zhong Xi Yi Jie He Xue Bao 2005, 3:286-289.
37. Yamanaka O., Saika S., Ohnishi Y., Kim-Mitsuyama S., Kamaraju A.K., Ikeda K. Inhibition of p38MAP kinase suppresses fibrogenic reaction in conjunctiva in mice. Molecular Vision 2007, 13:1730-1739.
38. Yu L., Hebert M.C., Zhang Y.E. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO Journal 2002, 21:3749-3759.
39. Yue J., Mulder K.M. Transforming growth factor-beta signal transduction in epithelial cells. Pharmacology and Therapeutics 2001, 91:1-34.
40. Zhao J.F., Liu C.H., Hu Y.Y., Xu L.M., Liu P., Liu C. Effect of salvianolic acid B on Smad3 expression in hepatic stellate cells. Hepatobiliary and Pancreatic Diseases International 2004, 3:102-105.